Swapnil Hiremath, MD, MPH

@hswapnil

Nephrologist, Mumbai|Boston now Ottawa. cofounder. Work at & & Opinions personal etc/No pharma conflicts

Ottawa, Canada
swapnilhiremath.com
Vrijeme pridruživanja: ožujak 2009.
7.361 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @hswapnil

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @hswapnil

  1. Prikvačeni tweet
    14. srp 2018.

    For contrast AKI, we need a better definition Suggestions: Essential criteria: - Oliguria - Contrast exposure Major criteria - No sepsis - No hypotension - nephrogram Minor criteria - bland sediment - low FENa - arterial contrast - high dose contrast - no other nephrotoxin

    ICYMI A brief history of the evolution of definitions and discuss considerations for end points for interventional studies using 4 commonly encountered clinical scenarios (FREE temporarily)
    Prikaži ovu nit
    14 replies 31 proslijeđeni tweet 100 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 3 sata

    ~~ToMoRrOw~~ Next Live Twitter Chat! Feb 6, 10:30-11:30am CDT Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients: Join US at with HIP author, Sarosh Rana ().

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    prije 15 sati

    8/ Step 3 turns a 12-page slog into a more manageable ~5 pages. But thankfully, you still won't need to read the rest of the pages start-to-finish. Instead, we'll actively extract what we need to get our answers

    1 reply 1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    prije 15 sati

    How to Critically Appraise a Trial in 10 Minutes: The NERDCAT Approach: The Tweetorial 1/

    7 replies 51 proslijeđeni tweet 126 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  5. proslijedio/la je Tweet
    prije 18 sati

    Gad Recap and Preview for GN Month -

    7 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    prije 17 sati

    ⚡️🎉Breaking News! Our paper is out 🤯 ⚡️Including injectable meds into an ESKD payment bundle did NOT increase the overall closure risk! ⚡️ 🥳

    Despite concerns that including injectable medications into an expanded ESKD payment bundle might lead to closure of dialysis facilities facing higher costs, new evidence shows this payment reform didn't increase the overall closure risk
    17 proslijeđenih tweetova 88 korisnika označava da im se sviđa
    Poništi
  7. proslijedio/la je Tweet
    prije 19 sati

    REMINDER: If you have not yet registered for the upcoming CNTN Spring Meeting, now is your chance! Spots are filling up quickly. Register today:

    2 proslijeđena tweeta
    Poništi
  8. proslijedio/la je Tweet
    prije 23 sata

    Great issue in , edited by Hiddo Heerspink, & - thanks for this fantastic resource: - Renal physiology - Use in T1DM - Non-diabetic CKD - Cardiovascular outcomes - Current use & future direction

    7 proslijeđenih tweetova 18 korisnika označava da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    prije 19 sati
    Odgovor korisnicima i sljedećem broju korisnika:

    Right now, DOAC is contraindicated with mechanical valves bass on RE-ALIGN trial. However, I’ve heard rumors of anti-Xa and newer (in development) drugs potentially being studied in mech valve. However, outside of clinical trial, I would stick to warfarin or LMWH only

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    prije 21 sat
    Odgovor korisnicima i sljedećem broju korisnika:

    Tissue valves don't need long-term anticoagulation unless for other reasons (eg, AF). In such cases, DOACs are fine. DOACs for mech AV are tougher. Obviously, there are clear risks but it might be the best of bad options. What type of mech AV? is who I would ask...

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  11. prije 21 sat

    Are you a PCP in the Ottawa area and have some time on Friday? Consider attending the course on Hypertension & CKD including talks by and many more

    3 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    prije 23 sata

    A randomized trial found adding the SGLT2 inhibitor empagliflozin to standard fluid restriction to treat patients with the syndrome of inappropriate antidiuresis resulted in a significant increase in sodium compared with

    1 reply 53 proslijeđena tweeta 109 korisnika označava da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    4. velj

    A Walking Intervention to Increase Weekly Steps in Dialysis Patients: A Pilot Randomized Controlled Trial

    6 proslijeđenih tweetova 21 korisnik označava da mu se sviđa
    Poništi
  14. proslijedio/la je Tweet
    4. velj

    Wonder could Scotland based medical professionals (incl. nurses/dietitians/co-coordinators) who refer/assess potential kidney transplant candidates could spend 3 mins filling out this survey on weight management for student Robbie McLaren?

    3 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    4. velj

    Reality check: why the US can’t solve its drug costs by draining Canada’s supply, with comments from ⁦ and ⁦⁦⁩ (Spoiler: we’re already short, and way smaller!)

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
    Poništi
  16. proslijedio/la je Tweet
    4. velj

    A number of recordings of talks from the Congress are available free online! Don't miss this excellent resource

    4 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
    Poništi
  17. proslijedio/la je Tweet
    4. velj

    Exposed covered stent in thigh AV graft present “for some time” and a lot of “he/she said he/she said” Always uncover and examine

    6 replies 8 proslijeđenih tweetova 38 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    4. velj

    Curious if and how folks are incorporating home BP measurements into HEDIS quality reporting. Seems these need to be automatically transmitted to providers but can’t be manually reported by patients.

    3 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  19. proslijedio/la je Tweet
    3. velj

    An immunofluorescence stain for megalin is shown. What is your diagnosis?

    6 replies 17 proslijeđenih tweetova 35 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  20. proslijedio/la je Tweet
    3. velj

    Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD (FREE until March 11, 2020)

    1 reply 12 proslijeđenih tweetova 18 korisnika označava da im se sviđa
    Poništi
  21. proslijedio/la je Tweet
    3. velj

    HD patient had SAVR & developed calciphylaxis on VKA - improved significantly after switching to LMWH. 4 months later, is there a place to put him on Apixaban? Is bad experience with DOACs based on dabigatran use only?

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Poništi

@hswapnil još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·